This inventor holds 2 USPTO granted patents. Top assignee: Cornell University. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Leo Brizuela: Innovator in Eukaryotic and Bacterial Pathogen Research
Introduction
Leo Brizuela is a notable inventor based in Hamilton, MA (US). He has made significant contributions to the field of pathogen research, particularly focusing on eukaryotic and bacterial infections. With a total of 2 patents, his work is paving the way for new therapeutic approaches.
Latest Patents
Brizuela's latest patents include innovative methods targeting adenylyl cyclases for the treatment of infections caused by eukaryotic pathogens. The first patent outlines a method for preventing or treating diseases caused by these pathogens through the administration of modulators of their adenylyl cyclase. This invention also encompasses pharmaceutical compositions that contain effective amounts of these modulators, as well as screening methods for identifying selective modulators that do not affect the host's adenylyl cyclase. The second patent focuses on bacterial infections, providing a similar approach by using modulators of bacterial adenylyl cyclase to prevent or treat diseases. This patent also includes methods for culturing bacterial pathogens and inducing pathogenic states in vitro.
Career Highlights
Leo Brizuela is affiliated with Cornell University, where he continues to advance his research in pathogen treatment. His work is instrumental in developing new strategies to combat infections that pose significant health risks.
Collaborations
Brizuela collaborates with esteemed colleagues such as Lonny Levin and Jochen Buck, contributing to a rich environment of innovation and research.
Conclusion
Leo Brizuela's contributions to the field of pathogen research through his patents and collaborations highlight his role as a key innovator. His work promises to enhance therapeutic options for treating infections caused by both eukaryotic and bacterial pathogens.